Insomnia Treatment: What Actually Works for Better Sleep

About one in three adults reports trouble sleeping in any given month. For most, it passes within a few nights. For an estimated 10 to 15 percent, the difficulty becomes chronic insomnia — trouble falling asleep, staying asleep, or waking too early at least three nights a week for three months or more, with daytime consequences.

Insomnia is treatable. The most effective treatments are also the most boring: behavioral therapy, sleep timing, and a short list of medications used at the right dose for the right person. The flashier options — cannabis products, supplements, prescription sleep aids advertised on TV — either do not work as well as advertised, or have downsides that make them poor long-term choices. This guide covers what the evidence actually supports.

Understanding Insomnia: Acute vs. Chronic

Sleep specialists divide insomnia into two patterns. Acute insomnia is short-term — usually triggered by stress, a schedule change, illness, or grief — and typically resolves within a few weeks once the trigger passes. Chronic insomnia is the diagnosis when symptoms persist three nights per week or more for three months, with daytime impairment (fatigue, irritability, trouble concentrating, mood changes).

The diagnostic line matters because the treatment is different. Acute insomnia rarely needs medication — the underlying stressor is the target. Chronic insomnia almost always benefits from structured behavioral treatment, with medication as an adjunct rather than the primary approach.

Common Causes and Triggers

Most chronic insomnia has more than one cause stacked on top of each other. The pattern usually starts with a trigger, then becomes self-sustaining through learned associations between bed and wakefulness. Common contributors include:

• Anxiety and depression. The most common psychiatric contributors. Bidirectional — poor sleep worsens mood; mood worsens sleep.
• Medications. Stimulants, decongestants, some antidepressants (especially SSRIs at the start), beta-blockers, and steroids.
• Substances. Caffeine after noon, alcohol within 3 hours of bed (suppresses REM and causes early-morning awakening), nicotine, late-evening cannabis use in some people.
• Medical conditions. Hyperthyroidism, chronic pain, GERD, restless legs syndrome, prostate enlargement causing nocturia, perimenopause hot flashes.
• Schedule disruption. Shift work, jet lag, inconsistent bedtimes.
• Conditioned arousal. Months of lying awake in bed teaches the brain to associate the bed with wakefulness rather than sleep. This is what makes chronic insomnia self-perpetuating.

First-Line Treatment: CBT-I

Cognitive Behavioral Therapy for Insomnia (CBT-I) is the gold-standard first-line treatment per the American Academy of Sleep Medicine and American College of Physicians. Multiple high-quality clinical trials show CBT-I outperforms sleep medications on almost every metric — including durability of effect after treatment ends. Medications stop working when you stop taking them; CBT-I keeps working.

CBT-I typically runs 6 to 8 sessions and combines several components:

• Stimulus control. Use the bed only for sleep. Get out of bed if you cannot fall asleep within about 20 minutes, do something quiet in dim light, and return only when sleepy. This breaks the bed-wakefulness association.
• Sleep restriction. Counterintuitively, you spend less time in bed at first — matching time-in-bed to actual sleep time — then gradually increase. This builds sleep pressure and consolidates fragmented sleep.
• Cognitive restructuring. Identify and challenge catastrophic thoughts about sleep ("If I do not sleep tonight, tomorrow will be ruined") that fuel arousal in bed.
• Relaxation training. Progressive muscle relaxation, diaphragmatic breathing, or guided imagery to reduce physiological arousal at bedtime.
• Sleep hygiene education. Less central than the other components but reinforces the rest.

CBT-I works for 70 to 80 percent of patients with chronic insomnia. It is available through trained therapists, digital programs (Sleepio, Somryst), and apps. Most patients notice improvement within 2 to 4 weeks.

Sleep Hygiene: What Helps and What Doesn't

"Sleep hygiene" gets oversold as a standalone treatment for chronic insomnia — it is not enough by itself for established cases — but the basics still matter and support CBT-I:

Medication Options (Non-Controlled)

Several non-controlled prescription options are appropriate for insomnia management via telehealth. Each has trade-offs:

• Trazodone (low dose, 25–100 mg). An older antidepressant used off-label for sleep. Cheap, non-habit-forming, and one of the most commonly prescribed sleep aids. Side effects: morning grogginess, rarely priapism in men.
• Doxepin (3–6 mg, Silenor). A tricyclic antidepressant at very low dose, FDA-approved for sleep maintenance insomnia. Mostly helps people who wake too early.
• Mirtazapine (7.5–15 mg). Useful when insomnia coexists with depression or appetite loss. Sedating at low doses, less so at higher doses.
• Hydroxyzine (10–50 mg). An antihistamine with anxiolytic properties. Useful when anxiety is the dominant driver. Avoid in older adults due to anticholinergic effects.
• Ramelteon (8 mg, Rozerem). A melatonin-receptor agonist FDA-approved for sleep onset insomnia. Non-habit-forming but expensive.
• Melatonin (0.5–5 mg). Over-the-counter. Works best for circadian rhythm issues (shift work, jet lag, delayed sleep phase) rather than chronic insomnia. Lower doses (0.5–1 mg) taken several hours before desired bedtime usually work better than the 5–10 mg doses commonly sold.

When Telehealth Is Appropriate

Insomnia is one of the conditions best suited to telehealth. The diagnosis is based on history rather than physical examination, treatment is medication and behavioral, and most patients benefit from regular follow-up visits to adjust the plan. A telehealth visit for insomnia at Innocre includes:

• A detailed sleep history (when symptoms started, sleep patterns, daytime impact)
• Screening for contributing conditions (sleep apnea risk, depression, anxiety, restless legs, thyroid)
• A treatment plan combining CBT-I principles with appropriate non-controlled medication if needed
• Referral to a sleep study or in-person provider if red flags are present
• Follow-up visits to assess response and adjust

When You Need an In-Person Visit Instead

Telehealth is not the right setting for everyone with insomnia. See a provider in person if:

• You have loud snoring, gasping, or witnessed apneas (needs a sleep study)
• You fall asleep involuntarily during the day or have unexplained excessive daytime sleepiness
• You are already on long-term benzodiazepines or Z-drugs and need to continue them
• You have suspected restless legs syndrome with sensory symptoms in the legs at night
• Insomnia is accompanied by significant suicidal ideation or psychotic symptoms

Frequently Asked Questions